Long Term Debt Summary of Sirona Biochem Corp.

Sirona Biochem Corp.'s latest annual long term debt in 2023 was 1.53 Million CAD , up 1494.49% from previous year.
Sirona Biochem Corp.'s latest quarterly long term debt in 2024 Q2 was 1.53 Million CAD , down -1.63% from previous quarter.
Sirona Biochem Corp. reported annual long term debt of 96.54 Thousand CAD in 2022, down -81.17% from previous year.
Sirona Biochem Corp. reported annual long term debt of 512.68 Thousand CAD in 2021, down -45.37% from previous year.
Sirona Biochem Corp. reported quarterly long term debt of 1.55 Million CAD for 2024 Q1, up 1.09% from previous quarter.
Sirona Biochem Corp. reported quarterly long term debt of 1.53 Million CAD for 2024 Q2, down -1.63% from previous quarter.

Annual Long Term Debt Chart of Sirona Biochem Corp. (2023 - 2006)

Historical Annual Long Term Debt of Sirona Biochem Corp. (2023 - 2006)

Year	Long Term Debt	Long Term Debt Growth
2023	1.53 Million CAD	1494.49%
2022	96.54 Thousand CAD	-81.17%
2021	512.68 Thousand CAD	-45.37%
2020	938.42 Thousand CAD	-10.15%
2019	1.04 Million CAD	-4.74%
2018	1.09 Million CAD	-43.92%
2017	1.95 Million CAD	109.12%
2016	934.84 Thousand CAD	28.4%
2015	728.07 Thousand CAD	9.6%
2014	664.28 Thousand CAD	7055.91%
2013	9283.00 CAD	-50.2%
2012	18.64 Thousand CAD	-60.04%
2011	46.64 Thousand CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q3	1.77 Million CAD	16.15%
2024 Q1	1.55 Million CAD	1.09%
2024 Q2	1.53 Million CAD	-1.63%
2023 Q1	112.35 Thousand CAD	16.37%
2023 Q3	1.56 Million CAD	10.29%
2023 Q2	1.41 Million CAD	1159.45%
2023 Q4	1.53 Million CAD	-1.36%
2023 FY	1.53 Million CAD	1494.49%
2022 Q4	96.54 Thousand CAD	-49.47%
2022 Q3	191.05 Thousand CAD	-35.92%
2022 Q1	419.35 Thousand CAD	-18.2%
2022 Q2	298.14 Thousand CAD	-28.91%
2022 FY	96.54 Thousand CAD	-81.17%
2021 Q4	512.68 Thousand CAD	-27.73%
2021 FY	512.68 Thousand CAD	-45.37%
2021 Q2	719.55 Thousand CAD	-15.7%
2021 Q1	853.56 Thousand CAD	-9.04%
2021 Q3	709.43 Thousand CAD	-1.41%
2020 Q1	964.21 Thousand CAD	-7.68%
2020 FY	938.42 Thousand CAD	-10.15%
2020 Q3	1.13 Million CAD	4.25%
2020 Q2	1.08 Million CAD	12.45%
2020 Q4	938.42 Thousand CAD	-16.98%
2019 FY	1.04 Million CAD	-4.74%
2019 Q4	1.04 Million CAD	-11.1%
2019 Q2	1.21 Million CAD	-5.09%
2019 Q1	1.28 Million CAD	17.1%
2019 Q3	1.17 Million CAD	-3.59%
2018 Q4	1.09 Million CAD	-8.91%
2018 FY	1.09 Million CAD	-43.92%
2018 Q3	1.2 Million CAD	-6.98%
2018 Q2	1.29 Million CAD	-3.55%
2018 Q1	1.34 Million CAD	-31.37%
2017 Q2	1.64 Million CAD	40.54%
2017 Q1	1.16 Million CAD	24.88%
2017 Q3	2.17 Million CAD	32.75%
2017 FY	1.95 Million CAD	109.12%
2017 Q4	1.95 Million CAD	-10.24%
2016 FY	934.84 Thousand CAD	28.4%
2016 Q2	723.54 Thousand CAD	-5.87%
2016 Q3	949.72 Thousand CAD	31.26%
2016 Q1	768.65 Thousand CAD	5.57%
2016 Q4	934.84 Thousand CAD	-1.57%
2015 Q4	728.07 Thousand CAD	0.4%
2015 FY	728.07 Thousand CAD	9.6%
2015 Q3	725.15 Thousand CAD	6.36%
2015 Q2	681.76 Thousand CAD	-5.78%
2015 Q1	723.59 Thousand CAD	8.93%
2014 Q3	171.51 Thousand CAD	4209.42%
2014 Q2	3980.00 CAD	-42.15%
2014 Q4	664.28 Thousand CAD	287.3%
2014 FY	664.28 Thousand CAD	7055.91%
2014 Q1	6880.00 CAD	-25.89%
2013 Q4	9283.00 CAD	-98.14%
2013 Q3	499.77 Thousand CAD	-0.45%
2013 Q2	502.03 Thousand CAD	27.24%
2013 Q1	394.55 Thousand CAD	2016.73%
2013 FY	9283.00 CAD	-50.2%
2012 Q2	31.03 Thousand CAD	-17.82%
2012 Q4	18.64 Thousand CAD	-21.7%
2012 Q3	23.8 Thousand CAD	-23.29%
2012 Q1	37.76 Thousand CAD	-19.03%
2012 FY	18.64 Thousand CAD	-60.04%
2011 FY	46.64 Thousand CAD	0.0%
2011 Q4	46.64 Thousand CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q2	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q2	- CAD	0.0%
2009 Q1	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 FY	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q4	- CAD	0.0%
2007 Q1	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q3	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 Q2	- CAD	0.0%
2006 FY	- CAD	0.0%

Peer Long Term Debt Comparison of Sirona Biochem Corp.

Name	Long Term Debt	Long Term Debt Difference
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	92.637%
Evofem Biosciences, Inc.	8000.00 USD	-19142.9%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	12.307%
Mesoblast Limited	100.29 Million USD	98.465%
Propanc Biopharma, Inc.	58.64 Thousand USD	-2525.136%
Genus plc	228.2 Million USD	99.325%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Marizyme, Inc.	667.12 Thousand USD	-130.755%
ContraFect Corporation	2.21 Million USD	30.342%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	-9.729%
Intellipharmaceutics International Inc.	- USD	-Infinity%
AXIM Biotechnologies, Inc.	5.42 Million USD	71.631%
MultiCell Technologies, Inc.	36.43 USD	-4225626.05%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	55.61 Million USD	97.232%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	30.843%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	-25.324%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	166.1 Million USD	99.073%
Oncotelic Therapeutics, Inc.	1.89 Million USD	18.912%
Skye Bioscience, Inc.	171.23 Thousand USD	-799.043%
Therapeutic Solutions International, Inc.	5512.00 USD	-27828.737%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	- USD	-Infinity%
IMV Inc.	27.39 Million USD	94.381%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	-378.084%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	11.23 Billion USD	99.986%
Halberd Corporation	150 Thousand USD	-926.288%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	300 Thousand USD	-413.144%
Nuo Therapeutics, Inc.	164.2 Thousand USD	-837.506%
argenx SE	15.35 Million USD	89.974%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	20.31 Million USD	92.421%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-34447.397%
Genscript Biotech Corporation	287.12 Million USD	99.464%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	-1118.85%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	-571.388%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	-177.58%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-5984.952%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	8.26 Million USD	81.372%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	265.63 Thousand USD	-479.529%
ONE Bio Corp.	592.19 Thousand USD	-159.952%
Reve Technologies, Inc.	1064.00 USD	-144583.459%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-928.936%
Regen BioPharma, Inc.	149.61 Thousand USD	-928.936%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	229.69 Thousand USD	-570.219%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	141 Thousand USD	-991.796%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	80 Thousand USD	-1824.29%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	80.314%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	-317.135%
International Stem Cell Corporation	445 Thousand USD	-245.94%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	81.111%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	-236.856%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	-32.595%
PureTech Health plc	18.25 Million USD	91.565%
Coeptis Therapeutics, Inc.	150 Thousand USD	-926.288%
IXICO plc	275 Thousand USD	-459.793%
IntelGenx Technologies Corp.	11.83 Million USD	86.997%
Gelesis Holdings, Inc.	26.3 Million USD	94.149%
CSL Limited	11.23 Billion USD	99.986%
Cellectis S.A.	36.21 Million USD	95.749%

Global Stocks Search

Sirona Biochem Corp. (SRBCF)

Long Term Debt Summary of Sirona Biochem Corp.

Annual Long Term Debt Chart of Sirona Biochem Corp. (2023 - 2006)

Historical Annual Long Term Debt of Sirona Biochem Corp. (2023 - 2006)

Peer Long Term Debt Comparison of Sirona Biochem Corp.